NEW YORK – The US Food and Drug Administration on Tuesday approved GSK's Wellcovorin (leucovorin calcium) as a treatment for adult and pediatric patients with cerebral folate deficiency who harbor ...
NEW YORK – Lyell Immunopharma has raised the second half of its planned $100 million private placement it launched last year, the company said Monday. The initial purchase agreement in July 2025 ...
NEW YORK – Korro Bio on Monday said it has inked a subscription agreement for a private investment in public equity (PIPE) financing that is expected to result in gross proceeds of about $85 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results